Daniel Bouthillier
Technik-/Wissenschafts-/F&E-Leiter bei DEVONIAN HEALTH GROUP INC.
Aktive Positionen von Daniel Bouthillier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Québec Biotechnology Innovation Centre
 Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Direktor/Vorstandsmitglied | - | - |
| Kanyr Pharma, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Daniel Bouthillier
Ehemalige bekannte Positionen von Daniel Bouthillier
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.11.1994 | 01.08.2010 |
Clinical Research Institute of Montreal
 Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Verwaltungsdirektor | - | - |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - | - |
| Kaneq Pharma, Inc. | Gründer | - | - |
Kaneq Bioscience Ltd.
 Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Vorstandsvorsitzender | 19.10.2012 | - |
| Gründer | 19.10.2012 | - | |
| Präsident | 19.10.2012 | - |
Ausbildung von Daniel Bouthillier
| University of Montréal | Doctorate Degree |
| HEC Montréal | Masters Business Admin |
Statistik
International
| Kanada | 10 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DEVONIAN HEALTH GROUP INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Kaneq Bioscience Ltd.
Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Health Technology |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Québec Biotechnology Innovation Centre
Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Health Technology |
| Kaneq Pharma, Inc. | |
Clinical Research Institute of Montreal
Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Commercial Services |
| Kanyr Pharma, Inc. |
- Börse
- Insiders
- Daniel Bouthillier
- Erfahrung
